MONTANARO, LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 6.093
AS - Asia 5.061
EU - Europa 3.937
AF - Africa 353
SA - Sud America 259
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.728
Nazione #
US - Stati Uniti d'America 6.023
CN - Cina 1.474
VN - Vietnam 1.323
SG - Singapore 1.313
IT - Italia 1.014
GB - Regno Unito 728
DE - Germania 437
SE - Svezia 432
HK - Hong Kong 296
FR - Francia 232
IN - India 200
RU - Federazione Russa 184
BR - Brasile 182
NL - Olanda 161
TG - Togo 142
UA - Ucraina 133
IE - Irlanda 125
KR - Corea 97
JP - Giappone 82
CH - Svizzera 79
ZA - Sudafrica 68
HR - Croazia 67
CI - Costa d'Avorio 65
FI - Finlandia 61
EE - Estonia 59
CA - Canada 55
AT - Austria 44
JO - Giordania 42
PL - Polonia 36
PH - Filippine 35
BE - Belgio 34
BG - Bulgaria 33
AR - Argentina 25
ID - Indonesia 24
TH - Thailandia 24
BD - Bangladesh 22
TW - Taiwan 22
DK - Danimarca 18
IQ - Iraq 17
TR - Turchia 17
DZ - Algeria 15
SC - Seychelles 15
AU - Australia 13
EC - Ecuador 12
MX - Messico 11
NG - Nigeria 11
EG - Egitto 10
GR - Grecia 10
IL - Israele 10
PK - Pakistan 10
CO - Colombia 9
SK - Slovacchia (Repubblica Slovacca) 9
TN - Tunisia 9
PY - Paraguay 8
RO - Romania 8
VE - Venezuela 8
ES - Italia 7
KE - Kenya 7
SA - Arabia Saudita 7
IR - Iran 6
MY - Malesia 6
UZ - Uzbekistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
MA - Marocco 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
LB - Libano 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
HU - Ungheria 3
KW - Kuwait 3
LV - Lettonia 3
PE - Perù 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
YE - Yemen 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NO - Norvegia 1
Totale 15.714
Città #
Singapore 924
Ashburn 633
Southend 608
Fairfield 541
Chandler 483
Bologna 320
Ann Arbor 316
Woodbridge 287
Dallas 285
Ho Chi Minh City 275
Houston 265
Hong Kong 264
Santa Clara 238
Seattle 237
Wilmington 232
San Jose 223
Hanoi 204
Dong Ket 201
Hefei 189
Cambridge 185
Beijing 156
Princeton 154
Lomé 142
Dublin 125
Boardman 111
New York 99
Los Angeles 92
Milan 91
Nanjing 90
Seoul 82
Lauterbourg 81
Jacksonville 72
Padova 72
Bern 69
Westminster 68
Tokyo 66
Abidjan 65
Berlin 55
Redwood City 55
Helsinki 48
Jinan 48
Council Bluffs 46
Da Nang 46
Shenyang 45
Amman 41
Hebei 40
Guangzhou 39
Buffalo 37
Frankfurt am Main 36
Turin 36
Shanghai 35
Brussels 33
Sofia 33
Vienna 33
Haiphong 32
Saint Petersburg 32
Warsaw 32
Redondo Beach 29
Bremen 28
San Diego 26
Tianjin 26
Changsha 25
Falkenstein 23
Zhengzhou 23
Florence 22
Haikou 21
London 20
Nanchang 20
Sherbrooke 20
São Paulo 20
Chicago 19
Jiaxing 19
Phoenix 18
Verona 18
Hải Dương 16
Ningbo 16
Norwalk 16
The Dalles 16
Brooklyn 15
Mülheim 15
Orem 15
Wayne 15
Bengaluru 14
Dearborn 14
Olalla 14
Redmond 14
Rome 14
Copenhagen 13
Montreal 13
Nuremberg 13
Xi'an 13
Atlanta 12
Des Moines 12
Falls Church 12
Hangzhou 12
Hyderabad 12
Shenzhen 12
Toronto 12
Abeokuta 11
Algiers 11
Totale 10.076
Nome #
Combined expression levels of KDM2A and KDM2B correlate with nucleolar size and prognosis in primary breast carcinomas 299
The pre-existing population of 5S rRNA effects p53 stabilization during ribosome biogenesis inhibition 280
A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes 254
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence 251
CLINICOPATHOLOGICAL, MOLECULAR AND ONCOLOGICAL FEATURES OF SPORADIC EARLY ONSET COLORECTAL CANCERS 250
DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells 250
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate 245
Human ribosomes from cells with reduced dyskerin levels are intrinsically altered in translation 242
Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis. 241
The nucleolar size is associated to the methylation status of ribosomal DNA in breast carcinomas. 234
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. 230
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53- deficient and proficient human osteosarcoma cell lines. 229
Location of rRNA transcription to the nucleolar components: disappearance of the fibrillar centers in nucleoli of regenerating rat hepatocytes. 229
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status 221
P53-dependent and p53-independent anticancer activity of a new indole derivative in human osteosarcoma cells 221
A 41-gene signature predicts complete response (CR) to Bortezomib-Thalidomide-Dexamethasone (VTD) as induction therapy prior to autologous stem-cell transplantation (ASCT) in multiple myeloma (MM). 220
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 220
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive value 213
Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. 212
RNA pseudouridylation in physiology and medicine: For better and for worse 209
Key role of the achievement of an appropriate ribosomal RNA complement for G1-S phase transition in H4-II-E-C3 rat hepatoma cells 205
Epigenetic up-regulation of ribosome biogenesis and more aggressive phenotype triggered by the lack of the histone demethylase JHDM1B in mammary epithelial cells 205
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. 204
How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies 204
Inhibition of human dyskerin as a new approach to target ribosome biogenesis. 203
The Ribosome Biogenesis-Cancer Connection 203
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. 202
5′-Untranslated region of heat shock protein 70 mRNA drives translation under hypertonic conditions 202
Cap-independent protein synthesis is enhanced by betaine under hypertonic conditions 200
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. 200
SnoRNA U50 levels are regulated by cell proliferation and rRNA transcription. 199
Bromodomain Inhibition Is Effective Against Acute Myeloid Leukemia Cells Under Hypoxia and Induces Genome-Dependent Metabolic Perturbations 196
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. 194
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis 187
The importance of being (slightly) modified: The role of rRNA editing on gene expression control and its connections with cancer 187
Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. 187
Initiation of mRNA Translation in Oncogenesis: The Role of eIF4E 185
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 184
Targeted inhibition of NMYC by peptide nucleic acid in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis 184
Relationship between the RB1 mRNA level and the expression of phosphorylated RB protein in human breast cancers: their relevance in cell proliferation activity and patient clinical outcome 179
ACETYL-CYSTEINE IMPROVES RESULTS OF LONG TERM CULTURE OF FROZEN/THAWED HUMAN OVARIAN TISSUE 179
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. 177
Turning uridines around: Role of rRNA pseudouridylation in ribosome biogenesis and ribosomal function 177
Healthy early preantral follicle can be obtained in a culture of frozen-thawed human ovarian tissue of 32 weeks. 176
COLTURE A LUNGO TERMINE (32 SETTIMANE) DI TESSUTO OVARICO UMANO CRIOCONSERVATO: EFFETTO DI IGF-II 174
Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10 171
Separated Siamese Twins: Intronic Small Nucleolar RNAs and Matched Host Genes May be Altered in Conjunction or Separately in Multiple Cancer Types 171
COLTURE A LUNGO TERMINE (32 SETTIMANE) DI TESSUTO OVARICO UMANO CRIOCONSERVATO: EFFETTO DI FSH E LH 169
The basal-like breast carcinoma phenotype is regulated by SLUG gene expression 169
Dyskerin and TERC expression may condition survival in lung cancer patients 167
Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells 165
How snoRNAs can contribute to cancer at multiple levels 163
JHDM1B expression regulates ribosome biogenesis and cancer cell growth in a p53 dependent manner 163
Ribosomal protein gene RPL9 variants can differentially impair ribosome function and cellular metabolism 163
Loss of Proteostasis Is a Pathomechanism in Cockayne Syndrome 162
Relationship between dyskerin expression and telomerase activity in human breast cancer. 160
Prognostic relevance of a novel semi-quantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. 160
Loss of retinoblastoma tumor suppressor protein makes human breast cancer cells more sensitive to antimetabolite exposure. 158
Nucleolar size and activity are related to pRb and p53 status in human breast cancer 158
Liquid Biopsy in the Management of Breast Cancer Patients: Where Are We Now and Where Are We Going 155
Controversial relationship between the expression of the RB pathway components and RB protein phosphorylation in human breast cancer 154
The emerging role of RNA polymerase I transcription machinery in human malignancy: a clinical perspective. 152
Current practice in bicistronic ires reporter use: A systematic review 152
Primer extension coupled with fragment analysis for rapid and quantitative evaluation of 5.8S rRNA isoforms 151
Nucleolus, ribosomes, and cancer. 141
null 139
What the nucleolus says to a tumour pathologist. 138
Alterations of ribosomal RNA pseudouridylation in human breast cancer 136
Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia 132
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy 132
Ribosomal RNA Pseudouridylation: Will Newly Available Methods Finally Define the Contribution of This Modification to Human Ribosome Plasticity? 131
DKC1 gene mutations in human sporadic cancer. 128
null 128
RiboAbacus: A model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes 125
The wild type p53 codon 72 arginine allele is more permissive for hypoxia survival in cancer cells 122
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report 120
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells 119
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation. 116
Ribosome biogenesis and control of cell proliferation: p53 is not alone. 115
Dyskerin and cancer: more than telomerase. The defect in mRNA translation helps in explaining how a proliferative defect ends up in cancer. 112
Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. 110
null 101
A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells. 100
Role of JHDM1B in Breast Cancer Development and Progression - AIRC IG 11416 97
Defining the molecular pathogenesis of the ribosomopathy cartilage hair hypoplasia - Telethon Exploratory Grant GEP 15019 96
Ribosome biogenesis and cancer 93
null 89
Publisher Correction: A reconstituted cell-free assay for the evaluation of the intrinsic activity of purified human ribosomes 85
null 81
Role of dyskerin as a tumor suppressor in human cancer 77
5.8S rRNA forms and ribosome heterogeneity in breast cancer 73
Primary endocervical extraosseous Ewing's sarcoma/PNET 72
null 69
Desmoplastic small round-cell tumor: A case report on the large cell variant with immunohistochemical, ultrastructural, and molecular genetic analysis 66
Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia 55
Retinoic acid modulates stem cell factor secretion by human neuroblastoma cell lines 48
Detection of fibronectin-binding protein genes in staphylococcal strains from peri-prosthesis infections 36
Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis 35
Qualitative and quantitative analysis of AgNOR proteins in chemically induced rat liver carcinogenesis 33
Totale 16.056
Categoria #
all - tutte 40.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021565 0 0 0 0 0 0 0 0 0 96 76 393
2021/20221.765 202 46 88 205 142 71 39 138 38 149 358 289
2022/20232.059 188 312 120 278 130 152 125 137 305 62 124 126
2023/2024558 57 76 20 63 54 98 29 44 17 30 37 33
2024/20252.399 101 309 216 154 359 133 282 109 20 196 108 412
2025/20264.983 426 641 481 399 563 300 435 165 1.193 380 0 0
Totale 16.056